To view the PDF file, sign up for a MySharenet subscription.

REMGRO LIMITED - Unaudited results for the six months ended 31 December 2015 and cash dividend declaration

Release Date: 14/03/2016 17:23
Code(s): REM     PDF:  
Wrap Text
Unaudited results for the six months ended
31 December 2015 and cash dividend declaration

REMGRO LIMITED
Registration number 1968/006415/06
ISIN ZAE000026480 Share code REM

INTERIM REPORT

UNAUDITED RESULTS FOR
THE SIX MONTHS ENDED
31 DECEMBER 2015
AND
CASH DIVIDEND DECLARATION

SALIENT FEATURES


-   Headline earnings per share                                     -1.0%
-   Interim dividend per share                                      +9.5%
-   Intrinsic net asset value per share compared to 30 June 2015:
       - 31 December 2015                                           -0.7%
       - 11 March 2016                                              +2.8%

                                                 REMGRO LIMITED

ABRIDGED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

                                                                    31 December    31 December       30 June
R million                                                                  2015           2014          2015
ASSETS   
   
Non-current assets   
Property, plant and equipment                                             6 131          5 677         5 716
Biological agricultural assets                                              458            425           550
Investment properties                                                        56             47            51
Intangible assets                                                         5 658          5 759         5 710
Investments - Equity accounted                                           67 014         54 718        57 831
            - Other                                                       3 499          2 811         2 493
Retirement benefits                                                         225            216           220
Loans                                                                     1 240            935           977
Deferred taxation                                                            35             15            18
                                                                         84 316         70 603        73 566
Current assets                                                           13 726         12 212        21 126
Inventories                                                               3 210          3 066         3 118
Biological agricultural assets                                              540            528           549
Debtors and short-term loans                                              4 546          3 654         3 837
Investments in money market funds                                         1 119            782           986
Cash and cash equivalents                                                 3 875          3 628         4 050
Other current assets                                                        396              8            52
                                                                         13 686         11 666        12 592
Assets held for sale(*)                                                      40            546         8 534
   
Total assets                                                             98 042         82 815        94 692
   
   
EQUITY AND LIABILITIES   
   
Stated capital                                                            3 605          3 605         3 605
Reserves                                                                 77 266         65 564        69 781
Treasury shares                                                           (248)          (281)         (272)
Shareholders’ equity                                                     80 623         68 888        73 114
Non-controlling interest                                                  2 953          2 695         2 803
Total equity                                                             83 576         71 583        75 917
Non-current liabilities                                                   5 589          2 236         5 404
Retirement benefits                                                         231            268           227
Long-term loans                                                           3 672            376         3 547
Deferred taxation                                                         1 686          1 592         1 630
Current liabilities                                                       8 877          8 996        13 371
Trade and other payables                                                  4 369          4 043         4 469
Short-term loans                                                          4 411          4 710           366
Other current liabilities                                                    97             72            69
                                                                          8 877          8 825         4 904
Liabilities held for sale(*)                                                  -            171         8 467
   
Total equity and liabilities                                             98 042         82 815        94 692
   
   
Net asset value per share (Rand)   
- At book value                                                         R156.66        R133.93       R142.12
- At intrinsic value                                                    R286.96        R284.48       R288.89


(*) Refer to "additional information" on page 7 for further detail.

ABRIDGED CONSOLIDATED INCOME STATEMENT
                                                                          Six months ended        Year ended
                                                                    31 December    31 December       30 June
R million                                                                  2015           2014          2015
Sales                                                                    14 255         13 110        25 590
Inventory expenses                                                      (8 795)        (8 537)      (15 267)
Staff costs                                                             (2 225)        (2 153)       (4 276)
Depreciation                                                              (325)          (299)         (607)
Other net operating expenses                                            (2 304)        (1 303)       (3 878)
Trading profit                                                              606            818         1 562
Dividend income                                                              30             15           213
Interest received                                                           130            135           276
Finance costs                                                             (297)          (198)         (371)
Net impairment of investments, loans, assets and goodwill                   (3)           (49)         (288)
Profit on sale of investments                                               234            722           696
Consolidated profit before tax                                              700          1 443         2 088
Taxation                                                                   (75)          (248)         (395)
Consolidated profit after tax                                               625          1 195         1 693
Share of after-tax profit of equity accounted investments                 2 864          3 241         7 228
Net profit for the period                                                 3 489          4 436         8 921

Attributable to:
Equity holders                                                            3 342          4 310         8 715
Non-controlling interest                                                    147            126           206
                                                                          3 489          4 436         8 921


EQUITY ACCOUNTED INVESTMENTS
Share of after-tax profit of equity accounted investments
Profit before taking into account impairments, non-recurring and
 capital items                                                            4 310          4 081         8 332
Net impairment of investments, assets and goodwill                        (631)          (158)         (213)
Profit on the sale of investments                                            96             35           271
Other non-recurring and capital items                                      (79)             28            62
Profit before tax and non-controlling interest                            3 696          3 986         8 452
Taxation                                                                  (778)          (690)       (1 129)
Non-controlling interest                                                   (54)           (55)          (95)
                                                                          2 864          3 241         7 228

RECONCILIATION OF HEADLINE EARNINGS
                                                                            Six months ended      Year ended
                                                                    31 December    31 December       30 June
R million                                                                  2015           2014          2015
Net profit for the period attributable to equity holders                  3 342          4 310         8 715
Plus/(minus)
- Net impairment of equity accounted investments                            (9)              -            99
- Impairment of other investments                                             -             44            79
- Impairment of property, plant and equipment                                12              5            94
- Impairment of assets held for sale                                          -              -            16
- Profit on sale of equity accounted investments(*)                        (82)          (944)         (984)
- (Profit)/loss on sale of other investments(*)                           (153)            222           288
- Net surplus on disposal of property, plant and equipment                 (18)           (10)           (5)
- Loss on disposal of biological agricultural assets                          9              -             -
- Non-headline earnings items included in equity accounted
  earnings of equity accounted investments                                  524             27         (231)
   - Net surplus on disposal of property, plant and equipment              (90)           (68)         (111)
   - Profit on the sale of investments                                     (96)           (35)         (271)
   - Net impairment of investments, assets and goodwill                     631            158           213
   - Other non-recurring and capital items                                   79           (28)          (62)
- Taxation effect of adjustments                                              1              -          (50)
- Non-controlling interest                                                  (2)              4          (25)
Headline earnings                                                         3 624          3 658         7 996

(*) For the period under review "Profit on sale of equity accounted investments" and "(Profit)/loss on sale of other
    investments" primarily consist of the profit of R94 million realised on the disposal of Britehouse and a profit of
    R153 million realised on the disposal of Spire to Mediclinic, respectively. In the comparative period these adjusting items
    primarily consisted of the profit of R958 million realised on the dilution of Remgro’s interest in Mediclinic and a loss of
    R222 million realised on the disposal of the investment in Lashou, respectively.

EARNINGS AND DIVIDENDS
                                                                        Six months ended               Year ended
                                                                    31 December    31 December            30 June
Cents                                                                      2015           2014               2015
Headline earnings per share
– Basic                                                                   704.4          711.7            1 555.0
– Diluted                                                                 699.5          704.2            1 541.8

Earnings per share
– Basic                                                                   649.5          838.5            1 694.9
– Diluted                                                                 644.7          830.5            1 680.9

Dividends per share
Ordinary                                                                 185.00         169.00             428.00
– Interim                                                                185.00         169.00             169.00
– Final                                                                       -              -             259.00

ABRIDGED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
                                                                            Six months ended           Year ended
                                                                    31 December      31 December          30 June
R million                                                                  2015             2014             2015
Net profit for the period                                                 3 489            4 436            8 921
Other comprehensive income, net of tax                                    5 476            (302)              335
Items that may be reclassified subsequently to the income     
  statement:   
  Exchange rate adjustments                                               2 175              231              267
  Fair value adjustments for the period                                     608            (145)            (156)
  Deferred taxation on fair value adjustments                              (57)              (6)             (34)
  Reclassification of other comprehensive income to the    
    income statement                                                      (635)              26                45
  Other comprehensive income of equity accounted investments              3 579               34              929
Items that will not be reclassified to the income statement:    
  Remeasurement of post-employment benefit obligations                        7               10                5
  Deferred taxation on remeasurement of post-employment benefit    
  obligations                                                               (2)              (3)              (2)
  Change in reserves of equity accounted investments                      (199)            (449)            (699)
    
Total comprehensive income for the period                                 8 965            4 134            9 276
    
    
Total comprehensive income attributable to:    
Equity holders                                                            8 819            4 008            9 066
Non-controlling interest                                                    146              126              210
                                                                          8 965            4 134            9 276
   



ABRIDGED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
                                                                            Six months ended           Year ended
                                                                    31 December      31 December          30 June
R million                                                                  2015             2014             2015
Balance at the beginning of the period                                   75 917           68 634           68 634
Total comprehensive income for the period                                 8 965            4 134            9 276
Dividends paid                                                          (1 377)          (1 237)          (2 136)
Capital invested by minorities                                               31                2               37
Other movements                                                              30               10               25
Long-term share incentive scheme reserve                                     10               40               81
Balance at the end of the period                                         83 576           71 583           75 917
    
ABRIDGED CONSOLIDATED STATEMENT OF CASH FLOWS
                                                                           Six months ended            Year ended
                                                                    31 December      31 December          30 June
R million                                                                  2015             2014             2015
Cash generated from operations                                              136              645            1 895
Taxation paid                                                             (192)            (132)            (397)
Dividends received                                                        2 032            1 382            3 215
Cash available from operating activities                                  1 976            1 895            4 713
Dividends paid                                                          (1 377)          (1 237)          (2 136)
Net cash inflow from operating activities                                   599              658            2 577
Investing activities                                                    (5 228)            (744)          (1 151)
Financing activities                                                      3 572             (58)          (1 349)
Net increase/(decrease) in cash and cash equivalents                    (1 057)            (144)               77
Exchange rate profit on foreign cash                                        391               71              116
Cash and cash equivalents at the beginning of the period                  3 829            3 636            3 636
Cash and cash equivalents at the end of the period                        3 163            3 563            3 829

Cash and cash equivalents – per statement of
financial position                                                        3 875            3 628            4 050
Bank overdraft                                                            (712)             (65)            (221)



ADDITIONAL INFORMATION
                                                                        31 December        31 December          30 June
                                                                               2015               2014             2015
Number of shares in issue
- Ordinary shares of no par value                                       481 106 370        481 106 370      481 106 370
- Unlisted B ordinary shares of no par value                             35 506 352         35 506 352       35 506 352
Total number of shares in issue                                         516 612 722        516 612 722      516 612 722
Number of shares held in treasury
- Ordinary shares repurchased and held in treasury                      (1 973 153)        (2 241 656)      (2 169 558)
                                                                        514 639 569        514 371 066      514 443 164

Weighted number of shares                                               514 516 070        513 998 313      514 200 979

In determining earnings per share and headline earnings per share the weighted number of shares was taken into account.

                                                                     31 December   31 December   30 June
R million                                                                   2015          2014      2015
Listed investments
Associated
- Book value                                                              50 275        38 633    41 533
- Market value                                                           101 272        96 351    97 926
Other
- Book value                                                               1 187          863        902
- Market value                                                             1 187          863        902

Unlisted investments
Associated
- Book value                                                              11 312        11 315    11 336
- Directors’ valuation                                                    22 380        23 703    22 516
Joint ventures
- Book value                                                               5 427         4 770     4 962
- Directors’ valuation                                                    12 818        11 173    13 295
Other
- Book value                                                               2 312         1 948     1 591
- Directors’ valuation                                                     2 312         1 948     1 591

Assets and liabilities held for sale
During June 2015, Remgro entered into an agreement with funds
managed by Cinven to acquire 119 923 335 Spire shares
(equivalent to a 29.9% shareholding in Spire). In conjunction with
the transaction, Remgro and Mediclinic concluded an agreement
whereby Mediclinic would acquire Remgro’s interest in Spire,
subject to a successful Mediclinic rights issue. Total assets and
liabilities are                                                                -             -     (175)
    Investment                                                                 -             -     8 275
    Trade and other creditors                                                  -             -   (8 276)
    Derivative instruments                                                     -             -     (174)

Various other assets and liabilities classified as held for sale              40           375       242
   Assets                                                                     40           546       259
   Liabilities                                                                 -         (171)      (17)

                                                                              40          375         67


Additions to and replacement of property, plant and
 equipment                                                                   575          372        853

Capital and investment commitments                                        15 231          798      5 847
Al Noor acquisition                                                       13 656            -          -
Mediclinic rights issue                                                        -            -      4 135
Various other commitments                                                  1 575          798      1 712
(Including amounts authorised, but not yet contracted for)

Guarantees and contingent liabilities                                        238          306        316

Dividends received from equity accounted investments set off
against investments                                                        2 027         1 404     3 077


Fair value remeasurements

The following methods and assumptions are used to determine the fair value of each class of financial instruments:
- Financial instruments available-for-sale and investment in money market funds: Fair value is based on quoted market prices
  or, in the case of unlisted instruments, appropriate valuation methodologies, being discounted cash flow, liquidation
  valuation and actual net asset value of the investment.
- Derivative instruments: The fair value of derivative instruments is determined by using mark-to-market valuations.

Financial instruments measured at fair value, are disclosed by level of the following fair value hierarchy:
Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2 – Inputs (other than quoted prices included within level 1) that are observable for the asset or liability, either directly
          (as prices) or indirectly (derived from prices); and
Level 3 – Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The following tables illustrate the fair values of financial assets and liabilities that are measured at fair value, by hierarchy
level:

R million                                                              Level 1         Level 2           Level 3            Total
31 December 2015
Assets
Available-for-sale                                                       1 187               -             2 312            3 499
Derivative instruments                                                       -             395                 -              395
Investment in money market funds                                         1 119               -                 -            1 119
                                                                         2 306             395             2 312            5 013
Liabilities
Derivative instruments                                                       -              14                 -               14


31 December 2014
Assets
Available-for-sale                                                         863               -             1 948            2 811
Derivative instruments                                                       -               6                 -                6
Investment in money market funds                                           782               -                 -              782
                                                                         1 645               6             1 948            3 599
Liabilities
Derivative instruments                                                       -              19                 -               19


30 June 2015
Assets
Available-for-sale                                                         902               -             1 591            2 493
Derivative instruments                                                       -              10                 -               10
Investment in money market funds                                           986               -                 -              986
                                                                         1 888              10             1 591            3 489
Liabilities
Derivative instruments                                                       -             190                 -              190

The following tables illustrate the reconciliation of the carrying value of level 3 assets from the beginning to the end of the
period:

                                                                                         31 December    31 December     30 June
R million                                                                                       2015           2014        2015
Available-for-sale
Balances at the beginning of the period                                                        1 591          1 762       1 762
Additions                                                                                         59            287         375
Disposals                                                                                       (29)           (57)       (484)
Exchange rate adjustments                                                                        348             80         148
Fair value adjustments through comprehensive income                                              343          (124)       (210)
Balances at the end of the period                                                              2 312          1 948       1 591

There were no transfers between the different levels.

Level 3 investments consist mainly of investments in the Milestone China entities (Milestone), the Kagiso Infrastructure
Empowerment Fund (KIEF) and the Pembani Remgro Infrastructure Fund (PRIF) amounting to R1 734 million, R320 million
and R178 million respectively. These investments are all valued based on the fair value of each investment's underlying
assets, which are valued using a variety of valuation methodologies. Listed entities are valued at the last quoted share price on
the reporting date, whereas unlisted entities' methods include discounted cash flow valuations and appropriate earnings and
revenue multiples.

Milestone's fair value consists of listed investments (40%), cash and cash equivalents (5%) and unlisted investments (55%).
74% of the unlisted investments were acquired during the previous financial year and were valued at cost or a subsequent
transaction price at which new investors invested into the underlying businesses as Milestone's management considers the
transaction price to be the fair value of the investments. The remaining investments were valued at approximately
R243 million. KIEF's investments were valued using the discounted cash flow method. PRIF's main asset is the investment in
ETG Group and it was valued using appropriate revenue and earnings multiples based on peer group companies to determine
a price-to-book valuation.

Changes in the valuation assumptions of the above unlisted investments will not have a significant impact on Remgro's
financial statements.

Related party transactions
During the period under review the most material related party transactions related to Remgro's facilitation of Mediclinic's
acquisition of Spire, as well as Remgro's participation in the combination of Mediclinic and Al Noor. Refer to the section
dealing with "Investment activities" for more detail on these transactions.

COMMENTS

1.   ACCOUNTING POLICIES

     The interim report is prepared in accordance with the recognition and measurement principles of International
     Financial Reporting Standards (IFRS), including IAS 34: Interim Financial Reporting, and in accordance with the
     requirements of the Companies Act (No. 71 of 2008), as amended, and the Listings Requirements of the JSE
     Limited. The financial statements have been prepared under the supervision of the Chief Financial Officer, Leon
     Crouse CA (SA). The financial statements have not been audited or reviewed.

     These financial statements incorporate accounting policies that are consistent with those of the previous financial
     periods.

2.   RESULTS
     Headline earnings
     For the period under review headline earnings decreased by 0.9% from R3 658 million to R3 624 million, while
     headline earnings per share decreased by 1.0% from 711.7 cents to 704.4 cents.

     Included in headline earnings for the period under review are certain once-off items relating to the transaction costs
     incurred with the Mediclinic rights issue and Al Noor transactions amounting to R128 million. Excluding these
     items, headline earnings increased by 2.6% from R3 658 million to R3 752 million, and headline earnings per share
     increased by 2.5% from 711.7 cents to 729.2 cents.

Contribution to headline earnings by reporting platform

                                                                                Six months ended
                                                                                                            Year ended
                                                                      31 Dec              %       31 Dec       30 June
R million                                                               2015         Change         2014          2015
Food, liquor and home care                                             1 250           28.3          974         1 531
Banking                                                                1 386            2.9        1 347         2 845
Healthcare                                                               787           17.5          670         1 734
Insurance                                                                455         (17.1)          549           986
Industrial                                                                 5         (28.6)            7           381
Infrastructure                                                            74         (18.7)           91           392
Media and sport                                                         (28)        (354.5)           11          (16)
Other investments                                                         31         (20.5)           39            84
Central treasury
  - finance income                                                        77           35.1           57           111
  - finance costs                                                      (219)              -            -             -
Other net corporate costs                                              (194)        (123.0)         (87)          (52)
Headline earnings                                                      3 624          (0.9)        3 658         7 996

Refer to Annexures A and B for segmental information.

Commentary on reporting platforms' performance

     Food, liquor and home care
     The contribution from food, liquor and homecare to Remgro's headline earnings amounted to R1 250 million (2014:
     R974 million), representing an increase of 28.3%. RCL Foods contribution to Remgro's headline earnings increased
     by 23.0% to R582 million (2014: R473 million). This increase is mainly the result of a release of R163 million
     relating to a provision raised as part of the Foodcorp acquisition for uncertain tax disputes. Excluding this
     remeasurement, RCL Foods' contribution to Remgro's headline earnings would have decreased by 3.6% to
     R456 million. During the period under review RCL Foods' Grocery, Pies, Speciality, Beverages, Animal Feed and
     Logistics businesses performed well, but the Sugar and Chicken businesses remained under pressure due to severe
     drought conditions and increased maize and wheat prices respectively. Unilever's contribution to Remgro's headline
     earnings increased by 57.4% to R307 million (2014: R195 million). This increase is mainly the result of revenue
     growth and margin improvement. Distell's contribution to headline earnings, which includes the investment in
     Capevin Holdings, amounted to R361 million (2014: R306 million). This increase is mainly the result of revenue
     growth and efficiency improvements across the business. Distell experienced strong performances from all product
     categories and also benefited from a substantially weaker rand against the major currencies in which it trades.
     
     Banking
     The headline earnings contribution from the banking division amounted to R1 386 million (2014: R1 347 million),
     representing an increase of 2.9%. FirstRand and RMBH reported headline earnings growth of 5.0% and 2.3%
     respectively, mainly due to growth in both interest income and non-interest income from FNB, RMB and WesBank.
     On a normalised basis, FirstRand and RMBH reported earnings growth of 9.2% and 8.9% respectively.
     
     Healthcare
     Mediclinic's contribution to Remgro's headline earnings amounted to R787 million (2014: R670 million). This
     increase is mainly due to solid performances by all three operating platforms, as well as the positive effect of the
     weaker rand. The significant corporate activity undertaken by Mediclinic during the period under review had an
     immaterial impact on Remgro's results for this reporting period, but will impact the results of the second six months.
     
     Insurance
     RMI Holdings' contribution to headline earnings decreased by 17.1% to R455 million. This decrease is mainly the
     result of a once-off profit in the comparative period, with the release of a put option liability at Discovery, which is
     excluded from RMI Holdings' normalised earnings. On a normalised basis, RMI Holdings reported an increase of
     3.6% in earnings, with Discovery and OUTsurance achieving good earnings growth of 7.5% and 24.7% respectively,
     offset by lower earnings from MMI Holdings (lower by 8.9%).
     
     Industrial
     Total's contribution to Remgro's headline earnings amounted to R51 million (2014: a loss of R112 million).
     Included in the contribution to headline earnings for the period under review is substantial unfavourable stock
     revaluations amounting to R144 million (2014: unfavourable stock revaluations of R275 million). These revaluations
     are the result of the volatility in the Brent Crude price and the rand exchange rate. Excluding these revaluations, the
     contribution increased by 19.6% from R163 million to R195 million. Remgro's share of the results of KTH
     amounted to a loss of R260 million (2014: loss of R62 million). KTH's results were negatively impacted by
     unfavourable fair value adjustments relating to its investments in Exxaro Resources Limited and MMI Holdings
     Limited preference shares. Air Products' and Wispeco's contribution to headline earnings amounted to R142 million
     and R54 million respectively (2014: R108 million and R48 million), while PGSI contributed R18 million to
     Remgro's headline earnings (2014: R25 million).
     
     Infrastructure
     Grindrod's contribution to Remgro's headline earnings amounted to R43 million (2014: R76 million). This decrease
     is mainly the result of weak commodity markets and significantly lower dry-bulk shipping rates. For the period
     under review the CIV group contributed R35 million to headline earnings (2014: R5 million). SEACOM reported a
     headline loss of R111 million for the period under review (2014: headline earnings of R40 million), with Remgro's
     share of this loss amounting to R28 million (2014: profit of R8 million). This decrease is mainly due to a higher
     depreciation charge on certain cable assets resulting from a change in the estimated useful life of these assets.
     
     Media and sport
     Media and sport interests primarily consist of the interests in eMedia and various sport interests, including interests
     in rugby franchises, as well as the Stellenbosch Academy of Sport. eMedia's contribution to Remgro's headline
     earnings decreased by 75.0% to R11 million (2014: R44 million), mainly due to lower advertising revenue and new
     business development costs. The sport interests' contribution to headline earnings amounted to a loss of R39 million
     (2014: loss of R33 million).
     
     Other investments
     The contribution from other investments to headline earnings amounted to R31 million (2014: R39 million), of
     which Business Partners' contribution was R21 million (2014: R20 million).
     
     Central treasury and other net corporate costs
     Finance income amounted to R77 million (2014: R57 million). This increase is mainly the result of higher average
     cash balances, as well as higher interest rates than in the comparative period. Finance costs consist of funding costs
     amounting to R91 million, which relates to the R3.5 billion borrowed in order to participate in the Mediclinic rights
     issue, as well as once-off transaction costs amounting to R128 million in respect of the bridge financing of the
     Mediclinic rights issue and Al Noor transactions. Other net corporate costs amounted to R194 million (2014:
     R87 million). The period under review includes transaction and funding costs amounting to R114 million relating to
     Remgro's acquisition of Spire Healthcare Group plc (Spire). Remgro recouped this amount from Mediclinic as part
     of the Spire disposal consideration, which resulted in a profit on disposal of investment of R153 million, excluded
     from headline earnings.
     
     Total earnings
     Total earnings decreased by 22.5% to R3 342 million (2014: R4 310 million). This decrease is mainly the result of a
     profit of R958 million realised on the dilution of Remgro's interest in Mediclinic in the comparative period when
     Mediclinic did a share issuance in which Remgro did not participate.

3.   INTRINSIC NET ASSET VALUE

     Remgro's intrinsic net asset value per share decreased by 0.7% from R288.89 at 30 June 2015 to R286.96 at
     31 December 2015. Refer to Annexure B for full details.

     As at 11 March 2016 the intrinsic net asset value per share was R297.11 (using updated market information and
     investment activities to date), representing an increase of 2.8% from R288.89 at 30 June 2015.

4.   INVESTMENT ACTIVITIES
     The most important investment activities during the period under review were as follows:

     Mediclinic International Limited (Mediclinic)

     Facilitation of Mediclinic's acquisition of Spire
     During June 2015 Remgro entered into an agreement with funds managed by Cinven to acquire 119 923 335 Spire
     shares (equivalent to a 29.9% shareholding in Spire) at a price of GBP3.60 per share for a total purchase consideration
     of GBP431.7 million (excluding transaction costs). The transaction was concluded early in July 2015 and Remgro
     financed the transaction through a combination of its own cash and external funding.
     
     In conjunction with the above transaction, Remgro and Mediclinic concluded an agreement whereby Mediclinic
     would acquire Remgro's interest in Spire, subject to Mediclinic raising the appropriate funds in order to conclude
     such a transaction. During August 2015 Mediclinic raised R10.0 billion through a rights issue in terms of which
     111 111 111 new Mediclinic shares were issued at a price of R90.00 per share. Remgro, by following its rights and
     by underwriting the balance of the rights issue, subscribed for an additional 51 342 886 Mediclinic shares totalling
     R4.6 billion. Following the successful conclusion of the rights issue, Mediclinic acquired Remgro's shareholding in
     Spire during August 2015 for an amount of R8.6 billion, equal to the purchase price, transaction and funding costs.
     Remgro thus effectively only facilitated the acquisition of Spire by Mediclinic.
     
     In order to participate in the above-mentioned rights issue Remgro obtained bridge financing amounting to
     R3.5 billion. During January 2016 Remgro (through its wholly owned subsidiary, Remgro Healthcare Holdings
     Proprietary Limited (Remgro Healthcare)) replaced the bridge financing by issuing fixed rate cumulative redeemable
     preference shares. These preference shares have a tenor of four years and the dividend rate is fixed at 7.7%, payable
     semi-annually.
     
     On 31 December 2015 Remgro's effective interest in Mediclinic was 42.5% (30 June 2015: 42.0%).
     
     Combination of Mediclinic and Al Noor Hospitals Group plc (Al Noor)
     On 14 October 2015 Mediclinic and Al Noor agreed on the terms for the combination of their respective businesses
     (the "Combination") pursuant to which Al Noor offered to acquire 100% of the issued share capital of Mediclinic.
     The transaction was concluded on 15 February 2016 and given the relative size of Mediclinic and Al Noor, the
     Combination was classified as a reverse takeover of Al Noor. The combined group was renamed Mediclinic
     International plc (Mediclinic plc) and it retained its premium listing on the Main Market of the LSE. Mediclinic plc
     also obtained an inward secondary listing on the main board of the JSE and it is expected to be admitted to the FTSE
     100 index of the LSE. Mediclinic shareholders received 0.625 Al Noor shares for every Mediclinic share held by
     them, based on the 5 day volume weighted average price up to and including 1 October 2015 of the Mediclinic
     shares on the JSE and of the Al Noor shares on the LSE (which was GBP5.20 and GBP8.32, respectively).
     
     In addition to the Al Noor shares received by Remgro and as an indivisible component of the Combination, Remgro
     also subscribed for an additional 72 115 384 shares in Al Noor at a subscription price of GBP8.32 per share for an
     aggregate amount of GBP600 million during February 2016 (the "Remgro Subscription"). In order to fund the Remgro
     Subscription, Remgro obtained bridge financing of which GBP400 million was borrowed offshore, while GBP200 million
     (or R4.3 billion) was borrowed in South Africa. During March 2016 Remgro (through its wholly owned subsidiary,
     Remgro Healthcare) will replace the local bridge financing with newly issued fixed rate cumulative redeemable
     preference shares amounting to approximately R4.4 billion. The preference shares have a tenor of five years and a
     fixed dividend rate of 8.3%, payable semi-annually.
     
     After the Combination and the Remgro Subscription, Remgro's effective interest in Mediclinic plc was 44.6%.

     Britehouse Holdings Proprietary Limited (Britehouse)
     During September 2015 Remgro disposed of its investment in Britehouse for a total consideration of R159.6 million.
     A profit of R93.7 million was realised on this transaction, which is excluded from headline earnings.

     Milestone China Funds
     During the period under review Remgro invested the remaining committed loan amount of $6.9 million to Milestone
     Capital Strategic Holdings. Remgro also invested a further $3.5 million in Milestone China Opportunities Fund III
     (Milestone III), thereby increasing its cumulative investment in Milestone III to $90.0 million. As at
     31 December 2015 the remaining commitment to Milestone III amounted to $10.0 million.

     Other
     Other smaller investments amounted to R75 million.

     Events after 31 December 2015
     Other than the above-mentioned Mediclinic transactions, there were no significant transactions subsequent to
     31 December 2015.

5.   INFORMATION REGARDING UNLISTED INVESTMENTS
     Unilever South Africa Holdings Proprietary Limited (Unilever)
     Unilever has a 31 December year-end, but its results for the six months to 31 December 2015 have been equity
     accounted in Remgro's results for the period under review. Unilever's contribution to Remgro's headline earnings
     for the six months under review increased by 57.4% to R307 million (2014: R195 million) due to good turnover
     growth and margin improvement.

     Unilever's restructuring costs for the six months under review amounted to R35 million (2014: R79 million) driven
     by investments in the Boksburg Liquid factory in order to drive cost efficiencies and centralisation of Unilever's
     transport, buying, planning and execution.

     Air Products South Africa Proprietary Limited (Air Products)
     Air Products has a September year-end, but its results for the six months ended 30 September 2015 have been
     included in Remgro's results for the period under review. Air Products' contribution to Remgro's headline earnings
     for the period under review increased by 31.5% to R142 million (2014: R108 million).

     Turnover for Air Products' six months ended 30 September 2015 increased by 30.7% to R1 363 million (2014:
     R1 043 million), while the company's operating profit for the same period increased by 32.7% to R426 million
     (2014: R321 million). The results for the current period were positively influenced by the commencement of new
     long term tonnage contracts.

     Air Products is the largest manufacturer of industrial gases in Southern Africa and also imports and distributes a
     variety of specialty gases and chemical products that are supplied to a wide range of industries including steel,
     chemicals, oil refining, resource minerals, glass, pulp and paper, food packaging as well as general manufacturing,
     fabrication and welding.

     The Bulk liquid and Packaged gas product volumes remain under pressure in an environment of low manufacturing
     activity.

     Kagiso Tiso Holdings Proprietary Limited (KTH)
     KTH is a leading black-owned investment company with a diversified asset portfolio covering the resources,
     industrial, media, financial services, healthcare, property and information technology sectors.

     KTH's contribution to Remgro's headline earnings for the year under review amounted to a loss of R260 million
     (2014: headline loss of R62 million). The decrease in earnings was mainly driven by KTH's net attributable share of
     negative fair value adjustments on its equity investment in Exxaro Resources Limited (R317 million) and preference
     shares in MMI Holdings Limited (R263 million).

     Income from equity accounted investments increased slightly to R245 million (2014: R219 million), with the major
     contribution coming from its investment in MMI Holdings Limited. Net finance costs increased to R209 million
     (2014: R176 million) mainly as a result of the incurring of debt to finance the acquisitions concluded during the
     period.

     Total South Africa Proprietary Limited (Total)
     Total has a December year-end, but its results for the six months to 31 December 2015 have been included in
     Remgro's results for the period under review. Total's contribution to Remgro's headline earnings for the six months
     to 31 December 2015 amounted to R51 million (2014: headline loss of R112 million).
     
     The results were negatively impacted by stock revaluation losses of R802 million (2014: loss of R1 535 million), as
     the international oil price decreased from US$61 per barrel, at 30 June 2015, to US$37 per barrel at
     31 December 2015.
     
     Total's turnover for the six months ended 31 December 2015 was R26 195 million (2014: R25 292 million). The
     positive result is due to an increase in the regulated margin which was given in December 2014 and favourable
     volume sales in the mining sector.
     
     There was no increase in the wholesale margin during the period. The rollout of RAS (split of regulated margin
     between retail and wholesale) had little impact on Total's operating profit, as expected, following dealers contract
     renegotiations.
     
     The company is intensifying its investments regarding the health, safety, environment and quality constraints at its
     depots, as well as at its service stations.
     
     NATREF (in which Total has an interest of 36.4%) experienced an improvement in refining margins during the
     period under review as compared to 2014, due to the combined impacts of a better economic environment for
     refiners, favourable exchange rate movements and an improved refinery operational performance.
     
     PGSI Limited (PGSI)
     PGSI's contribution to Remgro's headline earnings for the six months to 31 December 2015 amounted to
     R18 million (2014: R25 million). PGSI's turnover for the period under review remained flat at R1 975 million (2014:
     R1 974 million). The group's normalised operating profit, which excludes the impact of asset impairments,
     decreased from R141 million to R135 million as the group continues to operate in difficult market conditions,
     particularly in the automotive industry.
     
     The group's main operating subsidiary in South Africa, PG Group, manufactures and supplies glass for the building
     and automotive industries. The group's results for the two industries have been mixed with good growth being
     reported in the building sector, but not sufficient to offset the decline in profitability in the automotive sector.
     
     The group has shown positive growth in the building division's results in 2015, in spite of the challenging economic
     climate and weak demand. There has been significant rationalisation of the divisional structures to improve
     operational efficiency and profitability, coupled with encouraging profitable growth in the "Rest of Africa" markets.
     The weaker Rand has improved export margins and allowed the group to be more competitive in the local market
     against imported supply. Energy efficient glass solutions for buildings and the related building legislation is
     providing exciting opportunities for the residential building sector and the group is well placed to capture market
     share with high quality and competitive product offerings.
     
     The weaker performance in the PG Group automotive division was due to economic pressures on consumers, lower
     volumes of claims from the Insurance sector and a weaker demand in export markets. The group introduced the
     value-for-money Safevue range of windscreens for the high volume categories of motor vehicle in the South African
     autoglass aftermarket. This new range has stemmed the decline of market share. Furthermore, the patented Glass
     Medic repair capability and the 'Repair before Replace' offering, provides the group's customer base with a range of
     affordable solutions to manage their autoglass costs. The Shatterprufe division has reported strong gains with
     improving efficiencies, cost reductions and higher yields and the current levels of the Rand should assist the group's
     competitive position in 2016, particularly in the export markets where the group has entered into a strategic
     arrangement to develop products for export markets.
     
     The group refinanced its bank borrowing during February 2015 at more favourable rates which has resulted in
     reduced finance costs. The new bank facilities enable investments in capital projects to address the operational
     improvements planned to meet enhanced market requirements.
     
     It is anticipated that the group Building products division will continue to grow above the current economic growth
     forecast due to the impact of customer focused initiatives and new product offerings.
     
     Wispeco Holdings Proprietary Limited (Wispeco)
     Wispeco's turnover for the six months to 31 December 2015 increased by 27% to R1 064 million (2014:
     R838 million). This increase results from slightly higher selling prices due to higher raw material costs, a 5%
     increase in sales volume and the additional revenue generated by Pressure Die Casting Proprietary Limited (PDC).
     
     Headline earnings for the period under review increased by 12.5% to R54 million (2014: R48 million). Sales
     margins remain under pressure due to intense price competition against imports.
     
     A number of exciting projects reached completion during the period, most notably the commissioning of the 9th
     extrusion press in September 2015. The installation of the first vertical powder coating plant in Africa is nearing
     completion and production should commence in March 2016. The investment into PDC has now been bedded down
     - the business continues to export much of its output, capitalising on the opportunities presented by a weakened
     Rand.
     
     Wispeco continues to play a leading role in the development of aluminium products and software solutions for the
     architectural aluminium industry. The company is gaining prominence in the industrial arena as it penetrates deeper
     into various industrial applications of aluminium extrusions. The Sandton skyline is lined by many new prominent
     high-rise buildings in which Sheerline Solutions played a key role. Wispeco retained its level 4 BEE status and
     continues to spend much time and effort on upskilling previously disadvantaged and differently abled young
     individuals in the field of aluminium fabrication.
     
     Community Investment Ventures Holdings Proprietary Limited (CIV group)
     Remgro has an effective interest of 50.9% in the CIV group, which is active in the telecommunications and
     information technology sectors. The key operating company of the group is Dark Fibre Africa Proprietary Limited
     (DFA), which constructs and owns fibre-optic networks.
     
     The CIV group has a March year-end and therefore its results for the six months ended 30 September 2015 have
     been included in Remgro's results for the period under review. The CIV group's contribution to Remgro's headline
     earnings for the period under review amounted to R35 million (2014: R5 million) driven by increased revenue and
     operating performance from DFA.
     
     DFA's revenue for the six months ended 30 September 2015 increased by 13.5% to R529 million (2014:
     R466 million) mainly as a result of solid growth of 20.7% in annuity revenue. DFA's earnings before interest, tax,
     depreciation and amortisation for the period under review increased by 10.9% to R347 million. The current book
     value of the fibre-optic network is in excess of R5 billion. DFA has thus far secured a healthy annuity income of
     R77 million per month, with the majority thereof being on long-term contracts with customers.
     
     One of the main operating challenges that DFA continues to face is the slower than anticipated site build/last mile by
     customers that affects DFA's ability to link mobile operator base station sites or enterprise customers to the fibre
     network, which causes a delay in annuity revenue generation to offset increasing depreciation and finance charges
     incurred on network rollout costs. DFA experienced delays in wayleave approvals by the local councils planning
     their own fibre network and by property owners that prevent access to the buildings. To reduce the risk of the slow
     last mile rollout, DFA acquired Conduct Telecommunication on 1 April 2014. The Conduct business is now fully
     integrated into DFA. DFA started their Fibre to the Business (FTTB) rollout in April 2015 and has completed the
     access build to 2 481 buildings, adding an additional 6 009 end users to the network at 30 September 2015. Most of
     DFA's customers extended their initial contract periods of five years to either 10 or 15 years. The network uptime as
     at 30 September 2015 was an excellent 99.99%.
     
     At 30 September 2015, a total distance of 8 839 km (September 2014: 7 910 km) of fibre network had been
     completed in the major metropolitan areas and on long-haul routes.
     
     Mobile backhaul is a major growth driver for DFA due to the increased demand for mobile broadband. DFA has
     7 878 (September 2014: 6 660) base transceiver station sites on the network that cover three of the four mobile
     operators. The next growth drivers for DFA will be the enterprise market and the public sector, which have shown a
     definite increase in demand in the last two years. DFA has 4 590 enterprise market links and developed new products
     to meet the demand of the enterprise market. DFA monitors and maintains a total of 11 178 (September 2014: 8 523)
     customer circuits.
     
     DFA is also part of a consortium that is in the process of providing fibre connectivity to the Gauteng provincial
     government buildings and the surrounding schools as part of a separate project and is in the process to connect the
     first 100 schools. The company also initiated the deployment of proof of concepts Fibre to the Home (FTTH)
     projects in selected suburbs in Johannesburg. DFA was awarded the Ekurhuleni (EMM) tender to the value of
     R201 million and rollout will commence in early February 2016. 30% of the EMM project is forecasted to be
     completed by 31 March 2016 (financial year end).
     
     DFA has signed commercial lease agreements with 88 (September 2014: 64) customers that have Electronic
     Communication Network Licences ranging from the largest incumbents, to banks, to small niche operators. The
     revenue model is flexible to adapt to the customers' needs, and DFA either sells an indefeasible right of use
     agreement, which is a lump sum in advance, or on an annuity basis with multi-year contracts of mostly up to
     15 years. Presently, approximately 84% of total revenue is annuity revenue. The future value of the current annuity
     contract base is in excess of R9 billion. DFA is experiencing a customer churn rate of less than 1%.
     
     SEACOM Capital Limited (SEACOM)
     Remgro has an effective interest of 25% in SEACOM which operates Africa's largest international data network
     connecting Southern and Eastern Africa with Europe and Asia.
     
     SEACOM has a December year-end, but its results for the six months to 31 December 2015 have been included in
     Remgro's results for the period under review. SEACOM's contribution to Remgro's headline earnings for the period
     under review amounted to a loss of R28 million (2014: headline earnings of R8 million). The decrease in earnings is
     mainly due to a higher depreciation charge on certain cable assets resulting from a change in the estimated useful life
     of these assets, which did not have any impact on operating cashflow. In 2015, SEACOM also officially launched
     services directly to the corporate market under "SEACOM Business". Growth into this new market segment has
     marginally increased operating costs as customers are being acquired and revenue is only now ramping up.
     
     SEACOM provides high-capacity low-latency international data connectivity services to customers in the form of
     private data transmission and public IP-based services. These services are generally sold under 12- to 36-month lease
     contracts and as long-term indefeasible right of use (IRU) contracts, which include upfront cash payment and then
     annual maintenance charges over the term. Upfront revenue from IRUs is accounted for over the full term of 15 or
     20 years.
     
     SEACOM's core sales and revenue streams continue to come from its established base of Service Provider
     (wholesale) customers that also provide the basis for network scale, cost reductions and service innovation.
     SEACOM Business provides the platform for future growth and improved profitability as the number and size of
     corporate customers increases. SEACOM Business added over 250 corporate customers in 2015, and has a healthy
     pipeline to continue to grow sales and revenue in 2016. At the same time, SEACOM is working with partners to
     ensure that connectivity to corporates is done over fibre-optic solutions, allowing for future upgrades as data demand
     continues to accelerate and cloud-based IT solutions become the norm.
     
     eMedia Investments Proprietary Limited (eMedia)
     Remgro has an effective interest of 32.3% in eMedia (previously known as Sabido) that has a range of media
     interests, which include South Africa's only private free-to-air television channel, e.tv, its sister news service, eNews
     Channel Africa (eNCA), free-to-air satellite platform Platco Digital, Gauteng-based radio station, Yfm, and various
     studio facilities and production businesses.
     
     eMedia has a March year-end and therefore its results for the six months to 30 September 2015 have been included
     in Remgro's results for the period under review. eMedia's contribution to Remgro's headline earnings for the period
     under review amounted to R11 million (2014: R44 million).
     
     Following eMedia management's strategic decision to exit some non-core and certain underperforming entities
     within the group through disposal or closure thereof which include the production arms of a factuals unit in Sabido
     Productions and the Natural History Unit, the eNCA Africa division, e.tv China, Setanta and the Africa Channel, the
     group continues to focus on its core South African operations, being e.tv, eNCA, e.tv Multichannel, Openview HD
     (Platco), and its radio, production and property interests. The group is continuing with its strategy to develop its
     multi-channel and Openview HD platforms with a further investment of R112 million during the period. These
     investments, albeit costly and currently loss-making in the absence of significant revenue due to the delays in the
     rollout of Digital terrestrial television (DTT) and the slower than expected box uptake, are necessary to establish
     these platforms for future content development and channel creation. eMedia has, however, recently been increasing
     its investment to assist in an acceleration of the set-top box rollout, which enabled it to reach levels of 330 000 set-
     top boxes during December 2015.
     
     The abovementioned factors, as well as the adverse economic climate and the decline in market share towards the
     end of the last financial year has seen classical advertising revenue remain under continued pressure. The launch of
     the new schedule on 1 March 2015 and the increased investment in local programming has arrested the decline in
     market share and management is pleased to report that audiences have been steadily increasing since March 2015.
     As at August 2015, the available audience is once again reaching levels previously considered acceptable to e.tv.
     Due to the lag effect of the revenue share measured against the increased audience share, this has not been evidenced
     in the current period under review, but it should be restored soon to ensure a positive impact on the results for the
     remainder of the financial year. Despite the increased investment in local programming and the decline in revenue,
     e.tv continued to produce a positive result for the period.
     
     The concept of increased choice is becoming commonplace amongst South African television viewers. To bring
     viewers into the group stable, e.tv's multi-channel bouquet, currently available on satellite platform Openview HD,
     is the route to providing viewers who want choice with that possibility. eMedia expects better growth in the take-up
     of Openview HD set-top boxes in 2015/16 and, consequently, better revenues.

     eNCA continues to perform strongly as the best, by market share and revenue, of all television news services
     available in South Africa despite a slowdown in the license fee revenue received from DStv.

     DTT broadcasting in South Africa is in an imminent phase of migration from analogue to digital platforms. As soon
     as DTT rolls out, eMedia multi-channel offering will be available on more screens than ever before which is
     expected to increase revenues.

6.   TREASURY SHARES
     At 30 June 2015, 2 169 558 Remgro ordinary shares (0.5%) were held as treasury shares by a wholly owned
     subsidiary company of Remgro. As previously reported, these shares were acquired for the purpose of hedging
     Remgro's share incentive scheme.

     During the period under review no Remgro ordinary shares were repurchased, while 196 405 Remgro ordinary
     shares were utilised to settle Remgro's obligation towards scheme participants who exercised the rights granted to
     them.

     At 31 December 2015, 1 973 153 Remgro ordinary shares (0.4%) were held as treasury shares.

DIRECTORATE
Mr Neville Williams, head of corporate finance and member of the management board, was appointed as chief financial
officer designate on 17 September 2015 with a view to succeeding Mr Leon Crouse who retires at the end of March 2016.

DECLARATION OF CASH DIVIDEND
Declaration of Dividend No. 31
Notice is hereby given that an interim gross dividend of 185 cents (2014: 169 cents) per share has been declared out of
income reserves in respect of both the ordinary shares of no par value and the unlisted B ordinary shares of no par value, for
the half-year ended 31 December 2015.

A dividend withholding tax of 15% or 27.75 cents per share will be applicable, resulting in a net dividend of 157.25 cents per
share, unless the shareholder concerned is exempt from paying dividend withholding tax or is entitled to a reduced rate in
terms of an applicable double-tax agreement.

The issued share capital at the declaration date is 481 106 370 ordinary shares and 35 506 352 B ordinary shares. The income
tax number of the Company is 9500-124-71-5.

Dates of importance:

Last day to trade in order to participate in the dividend                         Friday, 8 April 2016
Shares trade ex dividend                                                         Monday, 11 April 2016
Record date                                                                      Friday, 15 April 2016
Payment date                                                                     Monday, 18 April 2016

Share certificates may not be dematerialised or rematerialised between Monday, 11 April 2016, and Friday, 15 April 2016,
both days inclusive.

In terms of the Company's Memorandum of Incorporation, dividends will only be transferred electronically to the bank
accounts of shareholders, while dividend cheques are no longer issued. In the instance where shareholders do not provide the
Transfer Secretaries with their banking details, the dividend will not be forfeited, but will be marked as "unclaimed" in the
share register until the shareholder provides the Transfer Secretaries with the relevant banking details for payout.

Signed on behalf of the Board of Directors.
Johann Rupert                                               Jannie Durand
Chairman                                                    Chief Executive Officer

Stellenbosch
14 March 2016

DIRECTORATE
Non-executive directors
Johann Rupert (Chairman), E de la H Hertzog (Deputy Chairman),
J Malherbe (Deputy Chairman),
S E N De Bruyn Sebotsa*,G T Ferreira*, P K Harris*,
N P Mageza*, P J Moleketi*, M Morobe*,
F Robertson*, H Wessels*
(*Independent)
Executive directors
J J Durand (Chief Executive Officer),
W E Bührmann, L Crouse

CORPORATE INFORMATION
Secretary
M Lubbe
Listing
JSE Limited
Sector: Industrials – Diversified Industrials
Business address and registered office
Millennia Park, 16 Stellentia Avenue, Stellenbosch 7600
(PO Box 456, Stellenbosch 7599)
Transfer Secretaries
Computershare Investor Services Proprietary Limited,
70 Marshall Street, Johannesburg 2001
(PO Box 61051, Marshalltown 2107)
Auditors
PricewaterhouseCoopers Inc.,
Stellenbosch
Sponsor
Rand Merchant Bank (A division of FirstRand Bank Limited)
Website
www.remgro.com

                                                      ANNEXURE A
                                    COMPOSITION OF HEADLINE EARNINGS
                                                                            Six months ended
                                                                   31 December        31 December
 R million                                                                2015               2014
 Food, liquor and home care
 Unilever                                                                  307                195
 Distell(1)                                                                361                306
 RCL Foods                                                                 582                473
 Banking
 RMBH                                                                      979                950
 FirstRand                                                                 407                397
 Healthcare
 Mediclinic                                                                787                670
 Insurance
 RMI Holdings                                                              455                549
 Industrial
 Air Products                                                              142                108
 KTH                                                                     (260)               (62)
 Total                                                                      51              (112)
 PGSI                                                                       18                 25
 Wispeco                                                                    54                 48
 Infrastructure
 Grindrod                                                                   43                 76
 CIV group                                                                  35                  5
 SEACOM                                                                   (28)                  8
 Other infrastructure interests                                             24                  2
 Media and sport
 eMedia                                                                     11                 44
 Other media and sport interests                                          (39)               (33)
 Other investments                                                          31                 39
 Central treasury
 Finance income                                                             77                 57
 Finance costs                                                           (219)                  -
 Other net corporate costs                                               (194)               (87)
 Headline earnings                                                       3 624              3 658
 Weighted number of shares (million)                                     514.5              514.0
 Headline earnings per share (cents)                                     704.4              711.7

Notes
1. Includes the investment in Capevin Holdings Limited.

                                                ANNEXURE B
                                  COMPOSITION OF INTRINSIC NET ASSET VALUE
                                                   31 December 2015                 30 June 2015
R million                                    Book value     Intrinsic value    Book value    Intrinsic value
Food, liquor and home care
Unilever                                          3 411               9 444         3 384              8 688
Distell(1)                                        3 633              11 003         3 157             11 098
RCL Foods                                         7 771               9 679         7 346             11 514
Banking  
RMBH                                             12 754              22 102        12 267             26 409
FirstRand                                         4 500               9 314         4 300             11 720
Healthcare  
Mediclinic                                       20 464              48 815        13 227             36 727
Insurance  
RMI Holdings                                      7 184              17 407         6 717             19 096
Industrial
Air Products                                        925               3 649           882              4 164
KTH                                               1 489               2 492         1 876              2 696
Total                                             1 360               1 493         1 428              1 785
PGSI                                                745                 745           672                672
Wispeco                                             658                 864           603                920
Infrastructure
Grindrod                                          4 247               1 955         4 016              2 329
CIV group                                         1 835               2 452         1 795              2 797
SEACOM                                              702               1 258           566              1 001
Other infrastructure interests                      518                 518           480                480
Media and sport
eMedia                                            1 157               1 766         1 126              2 094
Other media and sport interests                     388                 388           374                382
Other investments                                 3 883               3 955         3 047              3 266
Central treasury
Cash at the centre(2)                             4 086               4 086         4 019              4 019
Debt at the centre                              (3 360)             (3 360)             -                  -
Other net corporate assets                        2 273               2 659         1 832              2 224
Net asset value (NAV)                            80 623             152 684        73 114            154 081
Potential CGT liability(3)                                          (5 004)                          (5 466)
NAV after tax                                    80 623             147 680        73 114            148 615
Issued shares after deduction of shares
repurchased (million)                             514.6               514.6         514.4              514.4                        
NAV after tax per share (Rand)                  R156.66             R286.96        142.12             288.89

Notes
1. Includes the investment in Capevin Holdings Limited.
2. Cash at the centre excludes cash held by subsidiaries that are separately valued above (mainly RCL Foods and Wispeco).
3. The potential capital gains tax (CGT) liability is calculated on the specific identification method using the most 
   favourable calculation for investments acquired before 1 October 2001 and also taking into account the corporate 
   relief provisions. Deferred CGT on investments "available-for-sale" is included in "other net corporate assets" above.
4. For purposes of determining the intrinsic net asset value, the unlisted investments are shown at directors' valuation 
   and the listed investments are shown at stock exchange prices.



Date: 14/03/2016 05:23:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story